Arden Trust’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,657
| Closed | -$70K | – | 271 |
|
|
2022
Q3 | $70K | Sell |
14,657
-389
| -3% | -$2.05K | 0.02% | 255 |
|
|
2022
Q2 | $68K | Sell |
15,046
-60
| -0.4% | -$261 | 0.02% | 262 |
|
|
2022
Q1 | $72K | Sell |
15,106
-2,781
| -16% | -$15.4K | 0.01% | 265 |
|
|
2021
Q4 | $133K | Sell |
17,887
-140
| -0.8% | -$870 | 0.02% | 291 |
|
|
2021
Q3 | $102K | Sell |
18,027
-132
| -0.7% | -$763 | 0.02% | 288 |
|
|
2021
Q2 | $119K | Sell |
18,159
-707
| -4% | -$4.93K | 0.02% | 297 |
|
|
2021
Q1 | $153K | Sell |
18,866
-531
| -3% | -$4.34K | 0.03% | 302 |
|
|
2020
Q4 | $125K | Sell |
19,397
-192
| -1% | -$1.12K | 0.02% | 309 |
|
|
2020
Q3 | $71K | Sell |
19,589
-2,736
| -12% | -$11K | 0.01% | 302 |
|
|
2020
Q2 | $103K | Buy |
22,325
+2,314
| +12% | +$9.84K | 0.02% | 314 |
|
|
2020
Q1 | $68K | Buy |
20,011
+3,203
| +19% | +$14K | 0.01% | 436 |
|
|
2019
Q4 | $86K | Sell |
16,808
-3,769
| -18% | -$12.8K | 0.01% | 344 |
|
|
2019
Q3 | $49K | Sell |
20,577
-185
| -0.9% | -$491 | 0.01% | 359 |
|
|
2019
Q2 | $45K | Buy |
20,762
+148
| +0.7% | +$350 | 0.01% | 344 |
|
|
2019
Q1 | $55K | Buy |
20,614
+3,478
| +20% | +$15.1K | 0.01% | 372 |
|
|
2018
Q4 | $82K | Sell |
17,136
-6,948
| -29% | -$42.2K | 0.01% | 320 |
|
|
2018
Q3 | $228K | Sell |
24,084
-605
| -2% | -$5.82K | 0.04% | 338 |
|
|
2018
Q2 | $241K | Sell |
24,689
-697
| -3% | -$7.35K | 0.04% | 322 |
|
|
2018
Q1 | $267K | Sell |
25,386
-1,128
| -4% | -$11.1K | 0.04% | 319 |
|
|
2017
Q4 | $170K | Sell |
26,514
-89
| -0.3% | -$549 | 0.03% | 345 |
|
|
2017
Q3 | $203K | Sell |
26,603
-100
| -0.4% | -$664 | 0.03% | 352 |
|
|
2017
Q2 | $190K | Sell |
26,703
-283
| -1% | -$1.29K | 0.03% | 350 |
|
|
2017
Q1 | $105K | Sell |
26,986
-482
| -2% | -$1.41K | 0.02% | 336 |
|
|
2016
Q4 | $56K | Buy |
27,468
+9,568
| +53% | +$19.2K | 0.01% | 336 |
|
|
2016
Q3 | $48K | Sell |
17,900
-7,346
| -29% | -$21.4K | 0.01% | 318 |
|
|
2016
Q2 | $78 | Buy |
25,246
+2,285
| +10% | +$14.3K | 0.01% | 629 |
|
|
2016
Q1 | $195K | Buy |
22,961
+771
| +3% | +$6.52K | 0.02% | 590 |
|
|
2015
Q4 | $301K | Sell |
22,190
-690
| -3% | -$8.49K | 0.03% | 465 |
|
|
2015
Q3 | $220K | Buy |
22,880
+292
| +1% | +$4.27K | 0.02% | 619 |
|
|
2015
Q2 | $325 | Sell |
22,588
-2,102
| -9% | -$23.1K | 0.05% | 335 |
|
|
2015
Q1 | $221 | Buy |
24,690
+7,790
| +46% | +$56.4K | 0.03% | 389 |
|
|
2014
Q4 | $103K | Sell |
16,900
-919
| -5% | -$8.4K | 0.01% | 329 |
|
|
2014
Q3 | $188K | Sell |
17,819
-32
| -0.2% | -$362 | 0.03% | 329 |
|
|
2014
Q2 | $212K | Sell |
17,851
-662
| -4% | -$8.31K | 0.03% | 310 |
|
|
2014
Q1 | $276K | Sell |
18,513
-873
| -5% | -$13.8K | 0.03% | 291 |
|
|
2013
Q4 | $285K | Buy |
19,386
+1,145
| +6% | +$17.6K | 0.03% | 271 |
|
|
2013
Q3 | $310K | Sell |
18,241
-10,557
| -37% | -$186K | 0.04% | 254 |
|
|
2013
Q2 | $477K | Buy |
+28,798
| New | +$467K | 0.06% | 217 |
|
Other funds holding IMGN
RCM
RG
MC
DM
Arden Trust's IMGN Position: Q4 2022 in Review
Arden Trust sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 14,657 shares — an estimated $70K sold.
Arden Trust first reported a position in IMGN in Q2 2013 and held it in 38 quarters. The position peaked at $477K in Q2 2013. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.
- Arden Trust reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
- Arden Trust sold 14,657 Immunogen Inc shares in Q4 2022, an estimated $70K.
- Arden Trust first reported a position in Immunogen Inc in Q2 2013 and held it in 38 quarters.
- Arden Trust's Immunogen Inc position peaked at $477K in Q2 2013.
- 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.
Based on Arden Trust's 13F filing for Q4 2022, filed 20 Jan 2023.